EYPT
EyePoint Pharmaceuticals Inc

8,712
Mkt Cap
$1.23B
Volume
2.41M
52W High
$19.11
52W Low
$3.91
PE Ratio
-4.99
EYPT Fundamentals
Price
$14.36
Prev Close
$14.91
Open
$14.83
50D MA
$15.90
Beta
1.26
Avg. Volume
951,267.80
EPS (Annual)
-$2.32
P/B
5.18
Rev/Employee
$262,260.61
$71.61
Loading...
Loading...
News
all
press releases
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 4.4% - Time to Sell?
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 4.4% - What's Next...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?
EyePoint (EYPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·19h ago
News Placeholder
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Sees Unusually-High Trading Volume - Time to Buy?
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Sees Large Volume Increase - What's Next...
MarketBeat·1d ago
News Placeholder
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Rating of "Buy" by Brokerages
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT - Get Free Report) has been given a consensus rating of "Buy" by the seven brokerages that are covering the company, Marketbeat.com reports. One research...
MarketBeat·3d ago
News Placeholder
EyePoint Pharmaceuticals Teases Mid-2026 DURAVYU Wet AMD Data, Starts Phase III DME Program
EyePoint Pharmaceuticals (NASDAQ:EYPT) used a presentation at the Guggenheim Emerging Biotech Emerging Outlook Biotech Summit 2026 to outline upcoming clinical catalysts for its lead retinal program...
MarketBeat·5d ago
News Placeholder
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading 7.8% Higher - Here's Why
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Up 7.8% - What's Next...
MarketBeat·14d ago
News Placeholder
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 5.3% - Here's What Happened
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 5.3% - Should You Sell...
MarketBeat·27d ago
News Placeholder
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Average Recommendation of "Buy" by Brokerages
Shares of Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT - Get Free Report) have earned a consensus rating of "Buy" from the seven brokerages that are currently covering the stock, MarketBeat reports...
MarketBeat·28d ago
News Placeholder
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up - Time to Buy?
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up - What's Next...
MarketBeat·1mo ago
News Placeholder
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 4.6% - Here's Why
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 4.6% - What's Next...
MarketBeat·1mo ago
<
1
2
...
>

Latest EYPT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.